A clinical trial treating chronic complete spinal cord injury patients will be conducted in the United States, led by Wise Young, M.D., Ph.D.
Dr Young is the founding director of the W.M. Keck Center for Collaborative Neuroscience at Rutgers University and has been conducting umbilical cord blood mononuclear cell and lithium human clinical trials in Taiwan, Hong Kong, and China. The results from these trials were extremely encouraging.
“In the initial results from the phase II trial in Kunming, China, 75% of the participants (15 out of 20) recovered walking with a rolling walker.www.keck.rutgers.edu
Dr. Young’s Phase IIb clinical trial will test the effectiveness of treating people having a chronic complete spinal cord injury with umbilical cord blood cells, lithium, and intense walking training.
The trial is set to begin late this year.